← All trials
NCT00503971
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 1, 2007
- Primary completion
- Dec 1, 2008
- Completion date
- Dec 1, 2011
- First posted
- —
- Last posted
- —
- Enrollment
- 50
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- Spanish Lung Cancer GroupLead sponsor
- Badalona Hospital Germans Trias i PujolOverall official - principal investigator
- University of BarcelonaStudy chair
- University AlicanteStudy chair
- Badalona Hospital Germans Trias i PujolStudy chair
- MerckCollaborator
- Hospital Clinico Lozano BlesaStudy chair
- University of BarcelonaOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.